Detalhe da pesquisa
1.
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
N Engl J Med
; 384(7): 630-642, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596357
2.
A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
Pain Manag
; 13(4): 205-211, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183454
3.
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Obstet Gynecol
; 140(6): 920-930, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357960
4.
Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
Contraception
; 103(3): 137-143, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259782
5.
Physicians' views and practices concerning menopausal hormone therapy.
Maturitas
; 56(1): 30-7, 2007 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16797148
6.
Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites.
Contraception
; 74(2): 125-32, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16860050
7.
Consistency of condom use among low-income hormonal contraceptive users.
Perspect Sex Reprod Health
; 37(4): 184-91, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16380364
8.
Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
Int J Fertil Womens Med
; 48(4): 163-72, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-13677549
9.
Paternal influences on the timing of prenatal care among Hispanics.
Matern Child Health J
; 9(2): 159-63, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15965621